Leidos · 9 hours ago
Senior AI/ML Engineer (SWE-3)
Leidos is an industry and technology leader serving government and commercial customers with smarter, more efficient digital and mission innovations. They are seeking a motivated AI/ML prototype engineer to support the Corporate Discovery Services mission, focusing on developing innovative prototypes and deploying solutions for machine learning models. The role involves collaboration with mission stakeholders to create solutions that enhance data integration and analysis.
ComputerGovernmentInformation ServicesInformation TechnologyNational SecuritySoftware
Responsibilities
Collaborate closely with customers to enable acceleration to evaluate and tune machine learning models’ ability to integrate, reference, make inferences and consolidate data into a holistic view
Creatively write and evolve prototype techniques leveraging diverse architecture and methods
Provide database administration, dataflow engineering, data wrangling, and model development
Qualification
Required
Bachelor's degree in computer science or related technical field plus a minimum of eight (8) plus years of relevant experience or equivalent
Proficiency with, but not limited to, Python (i.e. SciKit-learn, TensorFlow, PyTorch), R, GIT and experience with Jupyter Notebooks
Ability to provide database administration for relational databases and TensorFlow
Candidates must possess an active TS/SCI with Polygraph to be considered for this role
Preferred
Proficiency in augmenting, providing context, and/or fine-tuning large language models for generative tasks using approaches such as but not limited to, retrieval augmented generation (RAG) and model context protocol (MCP)
Benefits
Paid Time Off
11 paid Holidays
401K with a 6% company match and immediate vesting
Flexible Schedules
Discounted Stock Purchase Plans
Technical Upskilling
Education and Training Support
Parental Paid Leave
Health and Wellness programs
Income Protection
Paid Leave
Retirement
Company
Leidos
Leidos is a Fortune 500® innovation company rapidly addressing the world’s most vexing challenges in national security and health.
Funding
Current Stage
Public CompanyTotal Funding
unknown2025-02-20Post Ipo Debt
2013-09-17IPO
Leadership Team
Recent News
MarketScreener
2025-12-16
2025-12-16
Company data provided by crunchbase